BEBT-109, A PAN-MUTANT-SELECTIVE EGFR INHIBITOR WITH POTENT ANTITUMOR ACTIVITY IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER

BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer

EGFR mutation-positive NSCLC tumors are highly heterogeneous, therefore, exploring an agent simultaneously targeting multiple EGFR mutations may be valuable for clinical practice.Compared with osimertinib, BEBT-109 shows more sensitive and extensive antitumor activity in EGFR mutant NSCLC, while sparing wild-type EGFR cell lines.Meanwhile, unlike t

read more

Blood Transfusion Requirements after Liver Biopsy

It is common practice to type and screen the blood before performing a percutaneous liver biopsy.Many practitioners think that this is unnecessary but Chocolate do not have a reason to change their practice.The requirements for transfusion after biopsy were determined in a consecutive sample of cases at a tertiary care teaching hospital with the us

read more


Using genomics, morphometrics, and environmental niche modeling to test the validity of a narrow-range endemic snail, Patera nantahala (Gastropoda, Polygyridae)

Terrestrial gastropods are among the most imperiled groups of organisms on Earth.Many species have a complex taxonomic history, often including poorly defined subspecies, most of which have not been the focus of modern systematics research.Genomic tools, geometric morphometrics, and environmental niche modeling were used to assess the taxonomic Res

read more